CABA
CABA
NASDAQ · Biotechnology

Cabaletta Bio Inc

$2.51
+0.18 (+7.73%)
As of Feb 8, 2:02 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 65.93M 59.67M 56.91M
Net Income 10.90M 11.06M 10.11M
EPS
Profit Margin 16.5% 18.5% 17.8%
Rev Growth +19.8% +7.9% +20.9%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 39.64M 43.73M 41.30M
Total Equity 178.07M 205.13M 195.57M
D/E Ratio 0.22 0.21 0.21
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 19.62M 16.47M 16.10M
Free Cash Flow 6.94M 6.70M 7.67M